HealthCo secures rent as hospital transitions begin
Healthscope remains current with its financial obligations, having paid 100% of all rent due across its hospital portfolio up to and including April..
Todas as matérias desta categoria, das mais recentes às mais antigas.
Healthscope remains current with its financial obligations, having paid 100% of all rent due across its hospital portfolio up to and including April..
Bioxyne (ASX:BXN) announced a strategic manufacturing agreement with the Canadian-based industry giant, Aurora Cannabis.
Lumos Diagnostics (ASX:LDX) announced its largest purchase order to date for its flagship FebriDx rapid point-of-care test.
Neurizon Therapeutics (ASX:NUZ) has unveiled compelling new preclinical data regarding its lead compound, NUZ-001.
Biopharmaceutical innovator Firebrick Pharma (ASX:FRE) has secured $1.5 million in firm commitments through a strategic placement.
Paradigm Biopharmaceuticals (ASX:PAR) confirmed that 50% of the required participants have now been dosed in its PARA_OA_012 Phase 3 clinical trial.
Alterity Therapeutics (ASX:ATH) announced alignment with the US Food and Drug Administration following a pivotal Type C meeting.
Aroa Biosurgery (ASX:ARX) has achieved a clinical milestone following the completion of its randomised controlled trial for Symphony.
Reece (ASX:REH) announced a comprehensive redesign of its remuneration framework for top-tier leadership.
Lumos Diagnostics (ASX:LDX) announced a US market expansion triggered by the US FDA granting a CLIA waiver for its flagship point-of-care test, FebriDx.
4DMedical (ASX:4DX) secured CE Mark clearance for its pioneering CT:VQ software.
Radiopharm Theranostics (ASX:RAD) has dosed the first patient in its Phase 1 clinical trial of RAD 402.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade